GE Healthcare AG - Maasol, Markierungsbesteck |
| 49136 | | 01 | | Maasol | | Markierungsbesteck | | V09EB01 | | Technetium (99mtc) Macrosalb | | 29.07.1988 | | |
|
Composition |
I): albuminum humanum macroaggregatum 1.75 mg, stannosi chloridum dihydricum 0.175 mg, natrii acetas trihydricus, poloxamerum 238, pro vitro.
II): pro usu: I) recenter radioactivatum 99m-technetio ut natrii pertechnetas. |
Packungsbestandteile |
| II): pro usu: I) recenter radioactivatum 99m-technetio ut natrii pertechnetas | | |
| II): pro usu: I) recenter radioactivatum 99m-technetio ut natrii pertechnetas | | |
| I | | Marker kit | | | | Active Agent | Dose |
---|
Albuminum Humanum Macroaggregate | 1.75 mg | Stannosi Chloridum Dihydricum | 0.175 mg |
| | Inactive agents |
---|
Sodium Acetate Trihydrate | Poloxamerum 238 |
|
|
Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
---|
No entries have been found. |
|